Xolair

Lea en español

Xolair
Xolair (the trade name for Omalizumab), is a drug that has been approved to treat teenagers and adults with severe allergic asthma since its introduction in Australia in 2002. Approved by the U.S. Food and Drug Administration (FDA) in 2014, it has been held out as being particularly effective for people who cannot be treated with H1 antihistamines or do not benefit from high doses of corticosteroids. It has also been used to treat people who suffer chronically from hives.

A number of adverse side effects have been linked to the use of Xolair, including:

  • Anaphylactic shock or anaphylaxis (a life-threatening allergic reaction)
  • Increased risk of heart disease
  • Increased risk of stroke
  • Masking of warning signs of certain cancers

If you or someone you love has suffered injury after being prescribed Xolair, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.

Defective Drugs & Medical Devices Topics

Latest Articles

Happy Veterans Day 2019

“Honoring the sacrifices many have made for our country in the name of freedom and democracy i…

Read More 08 Nov 2019, Friday

Deficiency Judgment and Foreclosures

A person borrowing money to buy a home assumes the loan is secured by the mortgage lien on the house…

Read More 07 Nov 2019, Thursday

How Can a Lawyer Help You Defend Against Foreclosure?

If you fall behind on your mortgage payments, your house might end up in foreclosure. However, there…

Read More 21 Oct 2019, Monday